Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Neomycin 0.5% / Betamethasone 0.1% eye ointment
1104010D0AAADAD
|
Betamethasone sodium phosphate (Ear/Eye/Nasal) | Betamethasone sodium phosphate | Eye | No data available |
|
Neomycin 0.5% eye drops
1103010N0AAAAAA
|
Neomycin sulfate (Eye) | Neomycin sulfate | Eye | No data available |
|
Neomycin 0.5% eye drops 0.5ml unit dose preservative free
1103010N0AAAEAE
|
Neomycin sulfate (Eye) | Neomycin sulfate | Eye | No data available |
|
Neomycin 0.5% eye ointment
1103010N0AAABAB
|
Neomycin sulfate (Eye) | Neomycin sulfate | Eye | No data available |
|
Neomycin 100mg/5ml oral solution
0501040N0AAAJAJ
|
Neomycin sulfate (Systemic) | Neomycin sulfate | Infections | No data available |
|
Neomycin 500mg/5ml oral solution
0501040N0AAAIAI
|
Neomycin sulfate (Systemic) | Neomycin sulfate | Infections | No data available |
|
Neon GK+ Glucose testing strips
0601060D0FFAAA0
|
Neon GK+ Glucose (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Neon GK+ Ketone testing strips
0601060W0BMAAA0
|
Neon GK+ (Reagent) (Ketone) | Ketone blood testing reagents | Endocrine System | No data available |
|
NeoRecormon 1,000units/0.3ml inj pre-filled syringes
0901030E0BCAQAP
|
NeoRecormon | Epoetin beta | Nutrition and Blood | No data available |
|
NeoRecormon 10,000unit inj cartridges
0901030E0BCAAAI
|
NeoRecormon | Epoetin beta | Nutrition and Blood | No data available |
|
NeoRecormon 100,000unit inj vials
0901030E0BCANAM
|
NeoRecormon | Epoetin beta | Nutrition and Blood | No data available |
|
NeoRecormon 20,000unit inj cartridges
0901030E0BCABAJ
|
NeoRecormon | Epoetin beta | Nutrition and Blood | No data available |
|
NeoRecormon 50,000unit inj vials
0901030E0BCACAK
|
NeoRecormon | Epoetin beta | Nutrition and Blood | No data available |
|
NeoRecormon 500units/0.3ml inj pre-filled syringes
0901030E0BCAPAN
|
NeoRecormon | Epoetin beta | Nutrition and Blood | No data available |
|
NeoRecormon 60,000unit inj cartridges
0901030E0BCAXAW
|
NeoRecormon | Epoetin beta | Nutrition and Blood | No data available |
|
Neosafe bandage 10cm x 2.7m
20020200536
|
Neosafe bandage 10cm x 2.7m | Arm Sling/Bandages | Dressings | No data available |
|
Neosafe bandage 7.5cm x 2.7m
20020200535
|
Neosafe bandage 7.5cm x 2.7m | Arm Sling/Bandages | Dressings | No data available |
|
Neosafe Self Adhesive Border dressing 9cm x 10cm
20030100345
|
Neosafe Self Adhesive Border dressing 9cm x 10cm | Wound Management & Other Dressings | Dressings | No data available |
|
Neosafe Self Adhesive Border dressing 9cm x 20cm
20030100346
|
Neosafe Self Adhesive Border dressing 9cm x 20cm | Wound Management & Other Dressings | Dressings | No data available |
|
Neosporin eye drops
1103010N0BFAAAH
|
Neosporin | Neomycin sulfate | Eye | No data available |
|
Neosport bandage 10cm x 4.5m
20020200338
|
Neosport bandage 10cm x 4.5m | Arm Sling/Bandages | Dressings | No data available |
|
Neosport bandage 15cm x 4.5m
20020200339
|
Neosport bandage 15cm x 4.5m | Arm Sling/Bandages | Dressings | No data available |
|
Neostigmine 10mg/5ml oral solution
1002010M0AAAFAF
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 15mg/5ml oral solution
1002010M0AAAIAI
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 2.5mg/1ml solution for injection ampoules
1002010N0AAABAB
|
Neostig metilsulf (parent) | Neostigmine metilsulfate | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.